Abbreviations used in this paper: GPN = glossopharyngeal neuralgia; MVD = microvascular decompression; SRS = stereotactic radiosurgery.
G lossopharynGeal neuralgia (GPN) is a rare disorder characterized by severe, stabbing pain of the ear, posterior tongue, and throat. Patients may also experience cardiac arrhythmias or syncope in conjunction with their pain in a small percentage of cases (2%-3%). 3, 14 The incidence of GPN is approximately 0.4 cases per 100,000 person-years compared with 28.9 cases per 100,000 person-years for trigeminal neuralgia. 1 Similar to trigeminal neuralgia, the treatment of GPN is typically medical therapy (antiseizure medications) initially, with surgery reserved for patients who continue to have pain or who experience significant side effects. 13, 14 Sectioning of the glossopharyngeal nerve and upper rootlets of the vagus nerve, or microvascular decompression (MVD), is associated with high rates of pain relief (80%-90%), 7, 10, 14, 15, 17 but persistent lower cranial nerve damage has been reported in 8% to 19% of patients. As an alternative to posterior fossa surgery, we report our experience of using stereotactic radiosurgery (SRS) for patients with medically resistant GPN.
Methods

Patient Characteristics
From May 2009 to August 2010, 5 patients (3 men, 2 women) with GPN underwent SRS at the Mayo Clinic in Rochester, Minnesota. The median patient age was 61 years (range 34-83 years) and the median pain duration was 5 years (range 1 month to 6 years). The pain was left-sided in 4 patients and right-sided in 1 patient. Four patients had persistent pain despite medical therapy, whereas 1 patient was pain-free on carbamazepine but developed thrombocytopenia. Three patients were evaluated in our otorhinolaryngology department before SRS to rule out Eagle syndrome, and also received topical cocaine placed on the region of the tonsil and pharynx as a diagnostic test for GPN. All 3 patients reported significant pain relief after topical cocaine was applied to the affected posterior oropharynx. No patient had previously undergone surgery for GPN. Two patients required ongoing antiplatelet therapy secondary to stent placement for coronary artery disease. One of these 2 patients had documented asystole in conjunction with his painful attacks. He was admitted to the intensive care unit and underwent SRS on a semiurgent basis as an alternative to posterior fossa surgery in consideration of his significant medi- Object. Glossopharyngeal neuralgia (GPN) is a rare pain disorder characterized by severe, stabbing pain of the ear, posterior tongue, and throat. The authors report their early experience of using stereotactic radiosurgery (SRS) as an alternative to posterior fossa surgery for patients with medically resistant GPN.
Methods. Five patients (3 men, 2 woman) with medically resistant GPN underwent Gamma Knife surgery. The radiosurgical target was the distal portion of the glossopharyngeal and vagus nerves at the jugular foramen (glossopharyngeal meatus). The maximum radiation dose in all cases was 80 Gy. The median follow-up after radiosurgery was 13 months (range 2-19 months).
Results. Three patients became pain-free at 2 days, 3 days, and 2 weeks, respectively, and were able to discontinue the medications taken preoperatively for their pain. None of these patients have suffered recurrent pain since becoming pain free. Two patients experienced no benefit from the procedure and underwent posterior fossa surgery 2 and 5 months after SRS. Both of these patients continued to have pain after posterior fossa surgery. One of these patients was later discovered to have a head and neck cancer as the cause of his pain. No patient developed hoarseness or dysphagia after radiosurgery.
Conclusions. This preliminary experience demonstrates that SRS is an option for patients with medically resistant GPN. Additional follow-up and a larger number of patients are needed to demonstrate the long-term safety and optimal radiation dosimetry for this indication. cal comorbidities. The other 4 patients were counseled that a posterior fossa exploration with either an MVD or nerve sectioning was the standard operation performed for medically unresponsive GPN, but these patients chose SRS as a less invasive option for their pain. All aspects of this study were approved by the Mayo Clinic Institutional Review Board. In accordance with Minnesota state statutes, patients were required to consent to a review of their medical records. No patient refused research authorization.
Radiosurgical Dosimetry
Radiosurgery was performed using the Leksell Gamma Knife Perfexion Unit (Elekta Instruments). Dose planning was performed using a combination of stereotactic Gd-enhanced spoiled gradient-recalled acquisition MR imaging and thin-slice CT. The radiosurgical target was the distal portion of the glossopharyngeal nerve at the level of the glossopharyngeal meatus ( ; the length of coverage of the 50% isodose line in this case was 6.6 mm. The maximum radiation dose in all cases was 80 Gy.
Follow-Up
After SRS, patients were instructed to continue their medications for GPN until they noted an improvement in their pain, and if they became pain-free, to taper off the medications over several weeks. Patients were contacted at 1 month, 3 months, and in December 2010, and asked about their pain status, medication usage, and whether they had any difficulty with swallowing or choking, or had noted a change in their voice. The median follow-up after SRS was 13 months (range 2-19 months).
Results
Three patients became pain-free at 2 days, 3 days, and 2 weeks, respectively, and were able to discontinue the medications taken preoperatively for their pain. None of these patients have suffered any recurrent pain since becoming pain free (at 13, 16, and 19 months follow-up).
One patient had no benefit from SRS and underwent an MVD 5 months after SRS. At surgery, a neurovascular compression of the lateral medulla and lower cranial nerves by a loop of the posterior inferior cerebellar artery was noted. Postoperatively, the patient had persistent pain and no new neurological deficits. Fourteen months after SRS the patient was noted to have fullness on the left side of his neck and was diagnosed with a squamous cell carcinoma. The patient was treated with combined chemotherapy and external beam radiation therapy.
One patient had persistent and increasing pain necessitating multiple hospital admissions in the weeks following SRS. Two months after SRS the patient underwent an MVD at another institution. At surgery, a neurovascular compression of the lateral medulla and lower cranial nerves was observed, caused by a loop of the posterior inferior cerebellar artery. Postoperatively, the patient continued to have ongoing pain and a repeated posterior fossa exploration was performed. The brainstem was well decompressed from her previous surgery so we sectioned the glossopharyngeal nerve and upper rootlets of the vagus nerve. Following her second surgery the patient showed no improvement and was recommended by the psychiatry department to undergo a comprehensive pain rehabilitation program. No patient developed hoarseness or dysphagia after SRS.
Discussion
The surgical management of medically unresponsive GPN consists of destructive and nondestructive procedures aimed at alleviating the patient's pain while not causing significant lower cranial nerve dysfunction. Rushton et al.
14 described the operations and results for 129 patients undergoing surgery between 1922 and 1977. The majority of patients (71) were treated by intracranial sectioning of the glossopharyngeal nerve at the jugular foramen, with patients after 1948 (44) undergoing sectioning of both the glossopharyngeal nerve and the upper rootlets of the vagus nerve). One hundred ten patients (85%) were described as experiencing good pain relief. However, 25 patients (19%) developed permanent or temporary dysphagia after the procedure. In 1977, Laha and Jannetta 5 reported on 6 patients undergoing a posterior fossa exploration for GPN, in which 3 patients underwent an MVD without concurrent nerve sectioning. Although only 1 of these 3 patients experienced complete pain relief, the authors proposed that neurovascular compression of the glossopharyngeal and vagus nerves was an important cause of GPN, and the pain could be relieved without having to section any nerves. Of note, Rushton et al. 14 commented that "interest has been renewed in the possibility that trigeminal neuralgia and GPN may be caused by compression of the nerves by arterial or venous loops," and they reported that a compression of the glossopharyngeal or vagus nerve by an arterial loop was mentioned in the operative reports of 19 patients. Taha  and Tew 17 reported on 14 patients with GPN who underwent operations between 1976 and 1987, undergoing extracranial sectioning of the superior laryngeal nerve (2 patients), percutaneous radiofrequency rhizotomy at the jugular foramen (2 patients), or intracranial sectioning of the glossopharyngeal nerve and upper rootlets of the vagus nerve either with (4 patients) or without (8 patients) a concurrent MVD. All 12 patients undergoing intracranial nerve sectioning were pain free at a mean follow-up interval of 10 years. Only 1 patient (8%) experienced permanent dysphagia. The authors concluded that intracranial sectioning of the glossopharyngeal and upper rootlets of the vagus nerves was a safe and effective procedure for patients with GPN. Despite the excellent results associated with destructive operations, more recent reports have focused primarily on the outcomes of MVD as a nonablative technique to treat patients with medically unresponsive GPN. 7, 10, 15 In these studies, the rate of complete pain relief ranged from 76% to 97%, with a lower cranial nerve complication rate between 3% and 11%.
Over the past 15 years SRS has become an accepted surgical option for patients with trigeminal neuralgia. 2, 4, 9, 12 Most studies support the concept that SRS is a destructive procedure similar to the various percutaneous needle-based operations for trigeminal neuralgia, and the development of new trigeminal deficits is associated with improved facial pain outcomes. As an extension of these studies, several centers have used SRS as a less invasive option than posterior fossa surgery for patients with GPN. 16, 18, 19 Although the total number of patients reported to date (9) remains very low, the best outcomes appear to be related to radiation doses of 75-80 Gy and targeting at the level of the glossopharyngeal meatus (Table 1) . In summary, 5 (71%) of 7 patients have been reported to have complete pain relief without medications when this dosimetry has been used for radiosurgery. None of these patients has experienced a recurrence of pain at a median of 13 months after SRS (range 11-19 months) and no patient to date has suffered injury to the lower cranial nerves following GPN SRS. However, cranial nerve morbidity has been documented several years after SRS, so it is possible with more patients treated and longer follow-up periods that lower cranial nerve damage will be reported as a complication of GPN SRS. Of note, the 2 patients in our series who did not benefit from SRS also experienced persistent pain after MVD, and 1 patient was later discovered to have a head and neck cancer as the cause of his pain. This highlights the possibility that this rare pain condition can be incorrectly diagnosed in a patient, despite thorough imaging and consultation with neurologists, otolaryngologists, and neurosurgeons with significant experience in the management of patients with head and neck pain.
Nonetheless, radiosurgical targeting for GPN is more difficult than in trigeminal neuralgia and must account for the complex anatomy of the lower cranial nerves and jugular foramen. Rhoton and Buza 11 conducted an autopsy study of 50 jugular foramina detailing the bone anatomy and adjacent neurovascular structures. The jugular is divided into a larger, posterolateral compartment (pars venosa) containing the jugular bulb and tenth and eleventh cranial nerves and a smaller anteromedial compartment (pars nervosa) containing the ninth cranial nerve. In most specimens (70%) these two parts were separated by a fibrous bridge connecting the petrous temporal bone to the occipital bone. The dura covering the jugular foramen has two openings, the glossopharyngeal meatus through which the ninth nerve passes to enter the pars nervosa, and the vagal meatus, through which vagus and spinal accessory nerves enter the anteromedial part of the pars venosa. The distance between the glossopharyngeal meatus and vagal meatus ranged from 0.5 mm to 4.9 mm. Linn et al. 6 reviewed MR imaging studies of 25 patients to determine if the glossopharyngeal, vagus, and accessory nerves could be individually identified using highresolution sequences. An axial 3D constructive interference in steady-state sequence correctly differentiated the cisternal segments of the glossopharyngeal and vagus nerves as well as the glossopharyngeal and vagal meatus in all 50 examined sides. To minimize potential spatial distortions associated with MR imaging, we believe it is important to fuse the stereotactic MR imaging with stereotactic CT to maximize the chance of accurately targeting the glossopharyngeal and vagus nerves, which are significantly smaller than the trigeminal nerve. Also, analogous to the early experience with trigeminal neuralgia radiosurgery, the low morbidity observed to date with GPN SRS makes dose escalation higher than 80 Gy reasonable in the hope of providing better pain outcomes. 8 A second dosimetric consideration would be to enlarge the SRS target to ensure that both the glossopharyngeal and vagus nerves are within the irradiated volume. Review of the dose plans of our 5 patients showed complete coverage of the distal glossopharyngeal nerve in all cases, but potentially inadequate coverage of the upper vagal rootlets in 3 cases. However, excluding the patient who was later discovered to have a head and neck cancer, complete pain relief was noted in 1 of 2 patients with inclusion of the upper vagal rootlets and in both patients with poor coverage of these fibers.
Conclusions
Stereotactic radiosurgery can be performed as a less-invasive procedure for patients with medically unresponsive GPN. Our preliminary results combined with other published case reports provide a basis for further study on the safety and optimal dosimetry for GPN SRS.
